MEP Mr. Gianluca Susta
INTA Committee
European Parliament
1049 Bruxelles- Belgium
Brussels, 5th of November 2010
Ref. EGA comments to the consolidated text on ACTA that reflects changes made during the
September 2010 Tokyo round1.
Dear Mr. Susta,
Continue Reading →
Knowledge Ecology International – Dept of State cables on Brazil negotiations on prices and patents for AIDS drugs
Country –
Brazil
Saturday, 13 October 2007
On Thursday afternoon, 10 July 2025, Knowledge Ecology Interational (KEI) delivered the following statement on agenda item 12(ii), Report from the Standing Committee on the Law of Patents (SCP). KEI statement on the Standing Committee on the Law of Patents… Continue Reading →
CR-prize-study-tor-2024 At the end of 2024, Congress was poised to enact a 1547 page appropriations bill with bipartisan support. Elon Musk blew up the bill, mounting an attack on the bill through X, the social media platform he controls. The… Continue Reading →
This is a PDF copy of the letter June 13, 2025 Robert F. Kennedy, Jr. Secretary U.S. Department of Health and Human Services 200 Independence Ave SW, Washington, DC 20201 RE: Request for issuance of authorization and consent to use… Continue Reading →
The USPTO has a request for comment on the need for a statutory experimental use exception for patents. (89 FR 53963). The USPTO uploads the comments to Regulations.Gov, docket PTO-C-2024-0023. KEI filed comments on September 10, 2024: KEI-Experimental-use-exception-10Sept2024 September 10,… Continue Reading →
The Bayer price for sorafenib/Nexavar in India is $47 per 200 milligram tablet. At a daily dose of 4 tablets, this comes to $5,637 per month, or more than $68 thousand per year. In 2010, per capita income in India was $1,330.
